Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2002 8
2003 10
2004 11
2005 7
2006 6
2007 7
2008 2
2009 6
2010 2
2011 5
2012 4
2013 3
2014 9
2015 6
2016 14
2017 25
2018 17
2019 15
2020 27
2021 25
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

179 results
Results by year
Filters applied: . Clear all
Page 1
Current and future pharmacological therapies for NAFLD/NASH.
Sumida Y, Yoneda M. Sumida Y, et al. Among authors: yoneda m. J Gastroenterol. 2018 Mar;53(3):362-376. doi: 10.1007/s00535-017-1415-1. Epub 2017 Dec 16. J Gastroenterol. 2018. PMID: 29247356 Free PMC article. Review.
Current and new pharmacotherapy options for non-alcoholic steatohepatitis.
Sumida Y, Yoneda M, Ogawa Y, Yoneda M, Okanoue T, Nakajima A. Sumida Y, et al. Among authors: yoneda m. Expert Opin Pharmacother. 2020 Jun;21(8):953-967. doi: 10.1080/14656566.2020.1744564. Epub 2020 Apr 1. Expert Opin Pharmacother. 2020. PMID: 32237916 Review.
Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis.
Sumida Y, Yoneda M, Tokushige K, Kawanaka M, Fujii H, Yoneda M, Imajo K, Takahashi H, Eguchi Y, Ono M, Nozaki Y, Hyogo H, Koseki M, Yoshida Y, Kawaguchi T, Kamada Y, Okanoue T, Nakajima A, Jsg-Nafld JSGON. Sumida Y, et al. Among authors: yoneda m. Int J Mol Sci. 2020 Mar 11;21(6):1907. doi: 10.3390/ijms21061907. Int J Mol Sci. 2020. PMID: 32168769 Free PMC article. Review.
Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone?
Sumida Y, Yoneda M, Toyoda H, Yasuda S, Tada T, Hayashi H, Nishigaki Y, Suzuki Y, Naiki T, Morishita A, Tobita H, Sato S, Kawabe N, Fukunishi S, Ikegami T, Kessoku T, Ogawa Y, Honda Y, Nakahara T, Munekage K, Ochi T, Sawada K, Takahashi A, Arai T, Kogiso T, Kimoto S, Tomita K, Notsumata K, Nonaka M, Kawata K, Takami T, Kumada T, Tomita E, Okanoue T, Nakajima A, Japan Study Group Of Nafld Jsg-Nafld. Sumida Y, et al. Among authors: yoneda m. Int J Mol Sci. 2020 Jul 13;21(14):4939. doi: 10.3390/ijms21144939. Int J Mol Sci. 2020. PMID: 32668632 Free PMC article. Review.
[Hepatocarcinogenesis in NASH].
Nakade Y, Sato K, Nakao H, Yoneda M. Nakade Y, et al. Among authors: yoneda m. Gan To Kagaku Ryoho. 2012 May;39(5):693-7. Gan To Kagaku Ryoho. 2012. PMID: 22584317 Review. Japanese.
Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
Sumida Y, Yoneda M, Seko Y, Ishiba H, Hara T, Toyoda H, Yasuda S, Kumada T, Hayashi H, Kobayashi T, Imajo K, Yoneda M, Tada T, Kawaguchi T, Eguchi Y, Oeda S, Takahashi H, Tomita E, Okanoue T, Nakajima A, Japan Study Group Of Nafld Jsg-Nafld. Sumida Y, et al. Among authors: yoneda m. Diagnostics (Basel). 2020 Aug 10;10(8):579. doi: 10.3390/diagnostics10080579. Diagnostics (Basel). 2020. PMID: 32785100 Free PMC article. Review.
COVID-19-associated liver injury (COVALI): role of hepatologists.
Sumida Y, Yoneda M. Sumida Y, et al. Among authors: yoneda m. J Gastroenterol. 2021 Aug;56(8):786-787. doi: 10.1007/s00535-021-01809-9. Epub 2021 Jul 2. J Gastroenterol. 2021. PMID: 34212231 Free PMC article. No abstract available.
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020.
Tokushige K, Ikejima K, Ono M, Eguchi Y, Kamada Y, Itoh Y, Akuta N, Yoneda M, Iwasa M, Yoneda M, Otsuka M, Tamaki N, Kogiso T, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K. Tokushige K, et al. Among authors: yoneda m. J Gastroenterol. 2021 Nov;56(11):951-963. doi: 10.1007/s00535-021-01796-x. Epub 2021 Sep 17. J Gastroenterol. 2021. PMID: 34533632 Free PMC article. Review.
179 results